Cases

PRELIMINARY PRINT Volume 598 U. S. Part 2 Pages 594–616 OFFICIAL REPORTS OF THE SUPREME COURT May 18, 2023 Page Proof Pending Publication REBECCA A. WOMELDORF reporter of decisions NOTICE: This preliminary print is subject to formal revision before the bound volume is published. Users are requ

PRECEDENTIAL UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT ________________ No. 25-1407 ________________ In re: Application of Amgen Inc. for Assistance Before a Foreign Tribunal CELLTRION USA, INC., Appellant ________________ On Appeal from the United States Di

OPINION AND ORDER JOHN E. STEELE, Senior District Judge. This matter comes before the Court on the defendants’ Motion for Summary Judgment (Doc. #82) filed on December 23, 2014. Plaintiffs filed a Response in Opposition (Doc. #89) on January 20, 2015. Defendants filed a Reply (Doc. # 92) on February 2, 2015, and plaintiffs filed a Sur-Reply (Doc. # 95) on February 10, 2015.

REPORT AND RECOMMENDATION SHIELDS, Magistrate Judge: This case was commenced as a qui tarn action pursuant to the Federal False Claims Act, 31 U.S.C. § 3729 (the “FCA”). Plaintiff Daniel Coyne, M.D. (“Coyne” or “Plaintiff’) brought the action as relator, seeking to represent the interests of the United States of America (the “United States”), the District of Columbia, and twenty-nine States (collectively the

Filed 4/9/20 CERTIFIED FOR PUBLICATION IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA SECOND APPELLATE DISTRICT DIVISION ONE AMGEN INC., B296563 Plaintiff and Respondent, (Los Angeles County Super. Ct. No. 18STCP03147) v. HEALTH CARE SERVICES, Defendant and Appellant. APPEAL from an order of the Superior Court o

Opinion PERREN, J. —Appellant, Amgen, Inc. (Amgen), hired respondent, Attorney Darrell G. Dotson. The employment contract was accompanied by an arbitration agreement and an appendix containing arbitration procedures. One of the provisions states; “Each party shall have the right to take the deposition of one individual and any expert witness designated by another party .... Additional discovery may be had where

181 Cal.App.4th 975 (2010) 104 Cal. Rptr. 3d 341 DARRELL G. DOTSON, Plaintiff and Respondent, v. AMGEN, INC., Defendant and Appellant. No. B212965. Court of Appeals of California, Second District, Division Six. January 21, 2010. *978 Paul, Hastings, Janofsky & Walker, James A. Zapp, Paul W. Cane, Jr.,

516 F.3d 530 (2008) State of WISCONSIN, Plaintiff-Appellee, v. AMGEN, INC., et al., Defendants, and Dey, Inc., Defendant-Appellant. No. 07-1999. United States Court of Appeals, Seventh Circuit. Argued January 11, 2008. Decided February 4, 2008. *531 Betty Eberle (argued), Miner, Barnhill & Galland, Madiso

TARANTO, Circuit Judge. Sandoz Inc. sued Amgen Inc. and Hoffman-La Roche Inc. to obtain a declaratory judgment that two patents, owned by Hoffman-La Roche and exclusively licensed to Amgen, are invalid and unenforceable and will not be infringed if Sandoz uses, offers to sell or sells, or imports a drug product “biosimilar” to Amgen’s Enbrel®. At the time it brought suit, Sand

TARANTO, Circuit Judge. This appeal involves an action brought by Amgen Inc. and Amgen Manufacturing Limited (collectively Amgen) against Apo-tex Inc. arid Apotex Corp. (collectively Apotex) under the Biologies Price Competition and Innovation Act of 2009 (Biologies Act or BPCIA). Apotex has an application pending with the Food and Drug Administration, filed under the Biologie

707 F.Supp.2d 123 (2010) The UNITED STATES of America; and The States of California, Georgia, Hawaii, Illinois, Indiana, Michigan, New Mexico, New York, and Tennessee; and The Commonwealths of Massachusetts and Virginia; and The District of Columbia; ex. rel. Kassie WESTMORELAND, Plaintiffs, v. AMGEN, INC.; International Nephrology Network renamed Integrated Nephrology Network, a d/b/a of Dialysis Purchasing Alliance, Inc.; AmerisourceBergen Spec

707 F.Supp.2d 123 (2010) The UNITED STATES of America; and The States of California, Georgia, Hawaii, Illinois, Indiana, Michigan, New Mexico, New York, and Tennessee; and The Commonwealths of Massachusetts and Virginia; and The District of Columbia; ex. rel. Kassie WESTMORELAND, Plaintiffs, v. AMGEN, INC.; International Nephrology Network renamed Integrated Nephrology Network, a d/b/a of Dialysis Purchasing Alliance, Inc.; AmerisourceBergen Spec

Opinion for the court filed by Circuit Judge NEWMAN. Opinion concurring-in-part and dissenting-in part by Circuit Judge LINN. NEWMAN, Circuit Judge. By complaint to the International Trade Commission under Section 337 of the Tariff Act of 1930 as amended, 19 U.S.C. § 1337, Amgen, Inc. charged that certain importations of recombinant human erythropoietin and derivatives thereof (collectively “EPO”) are

469 F.Supp.2d 655 (2007) State of WISCONSIN, Plaintiff, v. AMGEN, INC., Abbott Laboratories, Astrazeneca Pharmaceuticals, LP, Astrazeneca, LP, Aventis Pharmaceuticals, Inc., Aventis Behring, LLC, Baxter Healthcare Corporation, Ben Venue Laboratories, Inc. Boehringer Ingelheim Pharmaceuticals, Inc.,Boehringer Ingelheim Roxane, Inc., Bristol-Myers Squibb Co., Dey, Inc., Geneva Pharmaceuticals, Inc., Glaxosmithkline, Inc., Immunex Corporation, Ivax

287 F.Supp.2d 126 (2003) AMGEN, INC., Plaintiff, v. HOECHST MARION ROUSSEL, INC. and Transkaryotic Therapies, Inc., Defendants. No. CIV.A. 97-10814-WGY. United States District Court, D. Massachusetts. October 30, 2003. *127 D. Dennis Allegretti, Duane Morris LLP, Boston, MA, Linda A. Baxley, Day Casebeer Madrid Winters & Batc

(2008) HUMAN GENOME SCIENCES, INC., Plaintiff, v. AMGEN, INC. and Immunex Corp., Defendants. Civ. No. 07-780-SLR. United States District Court, D. Delaware. May 9, 2008. MEMORANDUM OPINION SUE L. ROBINSON, District Judge. I. INTRODUCTION Plaintiff Human Genome Sciences, Inc. ("HGS") filed the present action against Immunex Co

494 F.Supp.2d 54 (2007) AMGEN, INC., Plaintiff, v. F. HOFFMANN-LA ROCHE LTD., a Swiss Company, Roche Diagnostics GmbH, a German Company and Hoffmann-La Roche Inc., a New Jersey Corporation Defendants. No. CIV.A. 05-12237-WGY. United States District Court, D. Massachusetts. July 3, 2007. *55 *56

(2008) AMGEN, INC., Plaintiff, v. F. HOFFMANN-LA ROCHE LTD., Roche Diagnostics GmbH, and Hoffmann-La Roche Inc., Defendants. Civil Action No. 05-12237-WGY. United States District Court, D. Massachusetts. October 2, 2008. MEMORANDUM AND ORDER WILLIAM G. YOUNG, District Judge. Amgen Inc. ("Amgen") sought declaratory relief to prevent F.

234 F.Supp.2d 9 (2002) AMGEN INC., Plaintiff, v. Thomas SCULLY, Administrator, Centers for Medicare and Medicaid Services, HHS, and Tommy Thompson, Secretary, Department of Health and Human Services. Defendants No. CIV.A. 02-2259(EGS). United States District Court, District of Columbia. December 26, 2002. *10 Jonathan Abram, Hoga

480 F.Supp.2d 462 (2007) AMGEN, INC., Plaintiff, v. F. HOFFMANN-LA ROCHE LTD., a Swiss Company, Roche Diagnostics GmbH, a German Company and Hoffmann La Roche Inc., a New Jersey Corporation Defendants. No. CIV.A. 05-12237-WGY. United States District Court, D. Massachusetts. March 30, 2007. *463 *464<